Latest California Healthline Stories
New Southern California Medical School To Tackle Doctor Shortages
The Claremont Colleges plans to open a medical school in 2022, one of four to be announced or established in Southern California in recent years. It’s part of an effort to bring more physicians to underserved areas.
Déjà Voodoo: Pharma’s Promises To Curb Drug Prices Have Been Heard Before
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
Long Waits To See Doctors In Puerto Rico, Where Medical Needs Are Great Post-Maria
Kaiser Health News senior correspondent Sarah Varney reports on how the island’s mounting physician shortage is making it even more difficult to get care.
California’s ACA Rates To Rise 8.7% Next Year
The average increase in California is smaller than the double-digit hikes expected around the nation, due largely to a healthier mix of enrollees and more competition in its marketplace. Still, health insurance prices keep growing faster than wages and general inflation.
Children With Disabilities Endure Long Waits For Life-Changing Medical Equipment
Some California children with serious health care problems wait more than a year for wheelchairs, bath benches, commodes, specialized crutches and other crucial medical equipment. Critics blame the delays on a confusing bureaucratic maze of private insurers and public programs.
Gastos de bolsillo impiden que más personas reciban la droga que previene el VIH
Funcionarios de salud pública están intensificando esfuerzos para que más personas puedan consumir PrEP. Pero aseguradoras ponen trabas al uso de cupones.
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
Esperanza y cautela por una vacuna de bajo costo contra la diabetes tipo 1
La vacuna, conocida como BCG, se utiliza en varios países para prevenir la tuberculosis y durante mucho tiempo se ha sabido que también estimula el sistema inmunitario.
Retooled Vaccine Raises Hopes As A Lower-Cost Treatment For Type 1 Diabetes
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
Podcast: KHN’s ‘What The Health?’ ACA Under Fire. Again.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.